APP and Alzheimer disease: Generally, AD is characterized by amyloid‐beta peptide (Aβ) accumulation, impaired brain metabolism, altered neurotransmission, and neuronal loss (Querfurth and LaFerla 2010), and it is important to recognize how AD risk factors contribute to each of these characteristics.